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Iowa Department of Public Health 
Division of Behavioral Health/Bureau of Substance Abuse  
Opioid Update: August 2020 
 
The Iowa Department of Public Health (IDPH) offers the Opioid Update to share information 
about opioid use and Iowa’s efforts to address the national opioid epidemic. Please feel free to 
submit topics to Julie Jones at julie.jones@idph.iowa.gov.  
 
In this issue:  
 
● Iowa News 
● Opioid News 




Iowa Pharmacies Offer Free NARCAN® 
 
In an effort to further reduce the number of opioid-involved deaths in Iowa, the Iowa Department 
of Public Health (IDPH), in partnership with the Iowa Board of Pharmacy, is sponsoring a new 
initiative that makes NARCAN® 4mg nasal spray (naloxone) available for free at local 
pharmacies. Any individual 18 years of age or older can request to be screened by a pharmacist 
for eligibility to receive NARCAN®. If approved, the pharmacy may dispense up to two 
NARCAN® 4mg nasal spray kits at no charge to the recipient. 
 
“This allows Iowans to be prepared in the event they encounter someone experiencing a 
suspected opioid overdose, or perhaps use opioids themselves and want others they’re involved 
with to know they have it,” said IDPH Opioid Initiatives Director, Kevin Gabbert. “While the 
dynamics of opioid misuse are complicated, greater availability of naloxone can help keep 
people alive, offer a chance to get help, and begin a journey of recovery.” 
 
“This program completely eliminates financial barriers to access the antidote to opioid 
overdoses,” said Iowa Board of Pharmacy Executive Director Andrew Funk. “It’s wonderful to 
see the confidence the department has in pharmacies and pharmacists across the state of Iowa 
by its willingness to partner with pharmacists, one of the most accessible healthcare providers. 
I’m excited to see the impact that this new endeavor will have on the health of Iowans.” 
 
Past efforts to address opioid-involved deaths include issuing a statewide Naloxone Standing 
Order that made the medication available without a prescription, offering free naloxone kits to 
law enforcement agencies and emergency departments, and providing training to over 170 
stakeholders statewide to be trainers on recognizing and responding to opioid overdose.  
While these and other efforts across Iowa have led to a reduction in the number of opioid 
involved deaths (from 206 deaths in 2017 to 137 deaths in 2018), provisional data for 2019 
shows that the decrease did not continue and the state experienced an increase, with 157 
deaths reported to date. 
 
Anyone who may be in a position to assist in the event of an opioid overdose is encouraged to 
receive NARCAN® education and have a supply on hand. NARCAN® is safe and easy to use, 
but most importantly, it may save a life in the event of opioid overdose.  
 





New Indicator in NarxCare Report 
 
On May 20, 2020, the Iowa Prescription Drug Monitoring Program introduced a new indicator 
within a patient’s PDMP report that will alert the clinician if the patient was administered 
Naloxone by EMS and first responders. When a patient experiences a Naloxone administration 
event, an indicator within the patient's PDMP NarxCare report will be displayed. This indicator, 
in addition to the patient’s prescription drug history, is intended to enable authorized users of the 
PDMP to better support patient needs.    
 
The Iowa PDMP continues to deliver NarxCare, which aggregates and analyzes prescription 
information from providers and pharmacies and presents interactive, visual representations of 
that information, as well as advanced analytic insights and risk scores to help physicians, 
pharmacists, and care teams provide better patient safety and outcomes.   
 
NarxCare is available from within the Iowa PDMP web portal, which is located at: NarxCare  
 
It can also be accessed from within the Electronic Health Record via the PDMP Gateway, 




Coronavirus Pandemic Compounds Another Ongoing Crisis: The Opioid 
Epidemic 
 
This NPR interview with the director of the National Institute on Drug Abuse, Dr. Volkow 
discusses how coronavirus pandemic measures are compounding one of the worst epidemics in 
the United States: the opioid epidemic. Dr. Volkow describes the factors that are most likely 
contributing to an estimated 30% to 40% increase in opioid overdoses but also emphasizes that 
treatment works and remains available via telehealth.  
 
To read the entire article and listen to the interview, please click on the following link: WBUR  
Fatal overdoses climbed to record high in 2019, reversing historic progress 
According to preliminary Centers for Disease Control and Prevention (CDC) data, there were 
70,980 reported overdose deaths in 2019, which surpassed the peak of 70,699 overdose deaths 
in 2017. As Bod Anderson, chief of mortality statistics at the CDC’s National Center for Health 
Statistics states, “it seems that 2019 is the new high for drug overdose deaths. Data are still 
provisional at this point, but the increase in the last few months of 2019 was steep enough to 
push it over the top by a little more than two hundred deaths.” 
This article discusses the national data as well as the removal of barriers to telehealth that have 
occurred due to the COVID-19 pandemic. Kevin Gabbert, the Opioid Initiatives Director for the 
Iowa Department of Public Health shares that, “it’s unfortunate that an event such as the 
pandemic had to create that opportunity, but nonetheless it has allowed our providers to reach a 
large number of individuals they might not otherwise be able to” through the delivery of 
telehealth services. 
To read this article, please click on the following link: CDC 





Webinars and Trainings 
 
Why Opioid Misuse Messaging is an Essential Part of Your COVID-19 Response 
 
Recent research reflects that COVID-19 has led to increases in opioid misuse and opioid-
related overdoses. As your community responds to the COVID-19 pandemic, it is crucial to 
include evidence-based opioid misuse messaging in your planning. While this can be difficult 
with tightening budgets, leveraging best practices can help your team address this need quickly 
and efficiently. Learn how to overcome these challenges and develop your messaging strategy. 
This webinar will review research and insights showing the impact of COVID-19 on substance 
misuse, best practices for engaging high-risk audiences with evidence-based content, and 
messaging that can be used in your practice. 
 
To register for this webinar, please click on the following link: WEBINAR 
 
Join the Hepatitis C ECHO Learning Community 
 
Through didactic sessions and case presentations, the Hepatitis C ECHO (Extension for 
Community Healthcare Outcomes) is an interactive web-based program that provides 
community-focused primary care clinicians and clinical staff who provide treatment and care to 
individuals with HCV an opportunity to become experts in the delivery of Hepatitis C care 
through a mentoring-based initiative. These sessions are 90 minutes long and occur every third 
Tuesday of the month.  
 
To register, email ECHO@iowapca.org 
 
 
 
